Home Situations ALNY — Quality under pressure
Situation · 2026-08-07

ALNY — Quality under pressure

Innovation Premium Without Stability Buffer

Updated 2026-08-07 · Ref: Biotechnology
Key metrics — 2026-08-07
Peer score
67
Quality pct
77
Valuation pct
58
52w drawdown
-55.4%
21d vs sector
-27.3%
Peer group
Biotechnology
Situation summary

ALNY trades on an innovation premium, not on business stability. The stock’s 54% volatility shows how sharply it reacts to news. For this price, every setback counts double. A regulatory stumble could trigger a hard rerating.

Published by AssetNext · 2026-08-06

All companies with this signal today

View full list: Quality under pressure →

Related pages for ALNY
Full peer analysis for Alnylam Pharmaceuticals, Inc. →Similar companies to ALNYALNY peersAll ALNY comparisonsNasdaq-100 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-08-04 Quality under pressure 70 -55.4% -12.0%
2026-08-03 Quality under pressure 67 -55.1% -26.3%
2026-07-30 Profile and price weak 61 -58.2% -41.0%
2026-07-30 Quality under pressure 61 -58.2% -41.0%
2026-07-30 Quality under pressure 64 -58.2% -11.7%
2026-07-30 Profile and price weak 64 -58.2% -11.7%
2026-07-24 Gap to peers 65 -44.7% -3.6%
2026-07-24 Quality under pressure 63 -44.7% -17.3%
2026-07-20 Quality under pressure 63 -44.5% -17.0%

See ALNY's full peer analysis

Break down ALNY's structural position across all peer dimensions with the interactive app.

Open ALNY in AssetNext →